Rx Safety Triggers Tighten As Senate Continues Work On FDA Revitalization Act

Provisions that specify which information will trigger the requirement for a drug to have a Risk Evaluation and Mitigation Strategy have been added to the FDA Revitalization Act as Senate floor debate on the bill continues

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet